Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

PTC stock slides on new data for Huntington’s drug
BioPharma Dive
Monday, May 5, 2025 - 10:57pm
tags:
PTC Therapeutics, clinical trials, Huntington's disease, PTC518
Trump administration will defend FDA against abortion pill lawsuit, asks for dismissal
The Hill
Monday, May 5, 2025 - 10:54pm
tags:
DOJ, Donald Trump, FDA, abortion pill, mifepristone
Novo’s Wegovy inches closer to becoming first FDA-approved GLP-1 weight-loss pill
BioSpace
Monday, May 5, 2025 - 11:29am
tags:
Novo Nordisk, Wegovy, FDA, obesity, weight loss
Deerfield secures more than $600M for its next biotech venture fund
BioPharma Dive
Monday, May 5, 2025 - 11:25am
tags:
Deerfield Management, funding, biotech, venture capital
Several months after Exscientia merger, AI biotech outfit Recursion reworks pipeline
Fierce Biotech
Monday, May 5, 2025 - 11:24am
tags:
Recursion, Exscientia, artificial intelligence, drug discovery
Immutep takes immunotherapy a step further with 'impressive' survival data from Keytruda combo
Fierce Biotech
Monday, May 5, 2025 - 11:21am
tags:
IMMUTEP, immunotherapy, eftilagimod alfa, head and neck cancer, clinical trials
Capricor Therapeutics announces completion of mid-cycle review meeting with FDA on deramiocel for the treatment of Duchenne Muscular Dystrophy cardiomyopathy
Stock Titan
Monday, May 5, 2025 - 11:20am
tags:
Capricor, DMD, DMD cardiomyopathy, FDA, deramiocel
Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty
Investing.com
Monday, May 5, 2025 - 11:16am
tags:
Medtech, Zimmer Biomet, earnings
Iambic announces Enchant v2, its next generation AI model for predicting the clinical viability of drug discovery programs
BioSpace
Monday, May 5, 2025 - 11:13am
tags:
Iambic, Enchant v2, drug discovery, artificial intelligence
US Health Secretary Kennedy to testify before Senate panel May 14
MSN/Reuters
Monday, May 5, 2025 - 11:10am
tags:
Robert F Kennedy Jr., Senate, HHS
Wegovy treated a serious form of liver disease in a major clinical trial
NBC News
Monday, May 5, 2025 - 11:06am
tags:
Novo Nordisk, Wegovy, clinical trials, MASH, liver disease
After an up and down year, pharma’s R&D landscape is shifting again
Pharma Voice
Monday, May 5, 2025 - 10:25am
tags:
R&D, innovation, funding, IQVIA
Can other countries entice US scientists hit by Trump cuts?
Pharmaphorum
Monday, May 5, 2025 - 10:16am
tags:
science, scientists, Donald Trump, R&D
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
Motley Fool
Sunday, May 4, 2025 - 12:09pm
tags:
Eli Lilly, Novo Nordisk, Viking Therapeutics, CVS Health, pharma stocks, weight loss, obesity
Vertex discontinues AAV research for gene therapies
Fierce Biotech
Sunday, May 4, 2025 - 12:06pm
tags:
Vertex Pharmaceuticals, AAV gene therapy, gene therapy
AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion
Fierce Pharma
Sunday, May 4, 2025 - 12:05pm
tags:
AstraZeneca, Breztri Aerosphere, asthma, clinical trials
Under Trump Administration, Continued Full Coverage Of HIV PrEP Drugs Uncertain
Forbes
Sunday, May 4, 2025 - 12:03pm
tags:
HIV, PrEP, Donald Trump, Supreme Court
US FDA asks some fired pharma user fee negotiation staff to return
MSN/Reuters
Sunday, May 4, 2025 - 12:02pm
tags:
FDA, layoffs, user fees
Amgen’s Stelara biosimilar gets off to fast start
BioPharma Dive
Sunday, May 4, 2025 - 12:00pm
tags:
Amgen, Stelara, biosimilars, JNJ
Low-price drug nations catching ‘free ride’ on US innovation, report says
BioSpace
Friday, May 2, 2025 - 11:37am
tags:
drug pricing, innovation, Canada, Germany

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.